Advertisement

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics

  • Sam G. MoretonEmail author
  • Luke Szalla
  • Rachel E. Menzies
  • Andrew F. Arena
Theoretical and Methodological Perspective

Abstract

Psychedelic therapies can engender enduring improvements in psychological well-being. However, relatively little is known about the psychological mechanisms through which the salutary effects of psychedelics emerge. Through integrating extant research on psychedelics with contemporary existential psychology, we present a novel hypothesis that reduced death anxiety may be a key mechanism underpinning the therapeutic effects of psychedelics. In developing this hypothesis, we also provide a complementary review of mechanisms through which psychedelics may reduce death anxiety. We conclude that an awareness of the role of death anxiety in psychopathology has the potential to guide future research into psychedelic therapies.

Keywords

Psychedelics Psychedelic therapy Psilocybin LSD DMT Death anxiety Fear of death Transdiagnostic 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Akhtar S (2010) Freud’s Todesangst and Ghalib’s Ishrat-e-Qatra: two perspectives on death. In: The wound of mortality: Fear, denial, and acceptance of death. Aronson, Lanham, pp 1–20Google Scholar
  2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®), 5th edn., WashingtonGoogle Scholar
  3. Arndt J, Routledge C, Cox CR, Goldenberg JL (2005) The worm at the core: a terror management perspective on the roots of psychological dysfunction. Appl Prev Psychol 11:191–213CrossRefGoogle Scholar
  4. Barrett FS, Johnson MW, Griffiths RR (2015) Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol 29:1182–1190PubMedPubMedCentralCrossRefGoogle Scholar
  5. Barrett FS, Johnson MW, Griffiths RR (2017) Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personal Individ Differ 117:155–160CrossRefGoogle Scholar
  6. Baumeister RF (1991) Meanings of life. Guilford Press, New YorkGoogle Scholar
  7. Baumeister RF, Leary MR (1995) The need to belong: desire for interpersonal attachments as a fundamental human motivation. Psychol Bull 117:497–529PubMedCrossRefGoogle Scholar
  8. Becker E (1973) The denial of death. Free Press, New YorkGoogle Scholar
  9. Benson PL, Donahue MJ, Erickson JA (1993) The faith maturity scale: conceptualization, measurement, and empirical validation. Res Soc Sci Stud Relig 5:1–26Google Scholar
  10. Boulougouris J, Marks I (1969) Implosion (flooding)—a new treatment for phobias. Br Med J 2:721–723PubMedPubMedCentralCrossRefGoogle Scholar
  11. Bowlby J (1969) Attachment and Loss: Vol 1. Attachment. Basic booksGoogle Scholar
  12. Burke BL, Martens A, Faucher EH (2010) Two decades of terror management theory: a meta-analysis of mortality salience research. Personal Soc Psychol Rev 14:155–195CrossRefGoogle Scholar
  13. Caras GW (1996) The relationships among psychological separation, the quality of attachment, separation anxiety and death anxiety Dissertation Abstracts International. Section B: The Sciences and Engineering 56:3436Google Scholar
  14. Carhart-Harris R, Erritzoe D, Haijen E, Kaelen M, Watts R (2018a) Psychedelics and connectedness. Psychopharmacology 235:547–550PubMedCrossRefGoogle Scholar
  15. Carhart-Harris RL (2018) The entropic brain-Revisited NeuropharmacologyGoogle Scholar
  16. Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ (2016a) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3:619–627PubMedCrossRefGoogle Scholar
  17. Carhart-Harris RL et al (2012a) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci 109:2138–2143PubMedCrossRefGoogle Scholar
  18. Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, Feilding A, Nutt DJ (2016b) The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychol Med 46:1379–1390PubMedPubMedCentralCrossRefGoogle Scholar
  19. Carhart-Harris RL et al (2012b) Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull 39:1343–1351PubMedPubMedCentralCrossRefGoogle Scholar
  20. Carhart-Harris RL et al (2016c) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci 113:4853–4858PubMedCrossRefGoogle Scholar
  21. Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M (2018b) Psychedelics and the essential importance of context. J Psychopharmacol 32:725–731PubMedCrossRefGoogle Scholar
  22. Chatard A, Pyszczynski T, Arndt J, Selimbegović L, Konan PN, Van der Linden M (2012) Extent of trauma exposure and PTSD symptom severity as predictors of anxiety-buffer functioning. Psychol Trauma Theory Res Pract Policy 4:47CrossRefGoogle Scholar
  23. Cozzolino PJ (2006) Death contemplation, growth, and defense: converging evidence of dual-existential systems? Psychol Inq 17:278–287CrossRefGoogle Scholar
  24. Cozzolino PJ, Blackie LE (2013) I die, therefore I am: the pursuit of meaning in the light of death. In: The experience of meaning in life. Springer, pp 31-45Google Scholar
  25. Curran HV, Nutt D, de Wit H (2018) Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation. Psychopharmacology 235:373–375PubMedCrossRefGoogle Scholar
  26. dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JE (2018) Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol 11:889–902PubMedCrossRefGoogle Scholar
  27. Dechesne M, Pyszczynski T, Arndt J, Ransom S, Sheldon KM, Van Knippenberg A, Janssen J (2003) Literal and symbolic immortality: the effect of evidence of literal immortality on self-esteem striving in response to mortality salience. J Pers Soc Psychol 84:722PubMedCrossRefGoogle Scholar
  28. Deci EL, Ryan RM (2000) The" what" and" why" of goal pursuits: human needs and the self-determination of behavior. Psychol Inq 11:227–268CrossRefGoogle Scholar
  29. Drolet JL (1990) Transcending death during early adulthood: symbolic immortality, death anxiety, and purpose in life. J Clin Psychol 46:148–160PubMedCrossRefGoogle Scholar
  30. Eaton NR, Rodriguez-Seijas C, Carragher N, Krueger RF (2015) Transdiagnostic factors of psychopathology and substance use disorders: a review. Soc Psychiatry Psychiatr Epidemiol 50:171–182PubMedCrossRefGoogle Scholar
  31. Fava GA, Gatti A, Belaise C, Guidi J, Offidani E (2015) Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 84:72–81PubMedCrossRefGoogle Scholar
  32. Finch EC, Iverach L, Menzies RG, Jones M (2016) Terror mismanagement: evidence that mortality salience exacerbates attentional bias in social anxiety. Cognit Emot 30:1370–1379CrossRefGoogle Scholar
  33. Forstmann M, Sagioglou C (2017) Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness. J Psychopharmacol 31:975–988PubMedCrossRefPubMedCentralGoogle Scholar
  34. Frankl VE (1963) Man's search for meaning: an introduction to logotherapy. Simon and Schuster, New YorkGoogle Scholar
  35. Freud S (1953) The interpretation of dreams. In: Strachey J (ed) The standard edition of the complete psychological works of Sigmund Freud, Volumes IV & V, 1900–1901. Hogarth Press, London, p 480Google Scholar
  36. Freud S (1966) The psychopathology of everyday life. WW Norton & Company, New YorkGoogle Scholar
  37. Frias A, Watkins PC, Webber AC, Froh JJ (2011) Death and gratitude: death reflection enhances gratitude. J Posit Psychol 6:154–162CrossRefGoogle Scholar
  38. Furer P, Walker JR (2008) Death anxiety: a cognitive-behavioral approach. J Cogn Psychother 22:167CrossRefGoogle Scholar
  39. Furer P, Walker JR, Chartier MJ, Stein MB (1997) Hypochondriacal concerns and somatization in panic disorder. Depress Anxiety 6:78–85PubMedCrossRefPubMedCentralGoogle Scholar
  40. Greenberg J, Pyszczynski T, Solomon S, Rosenblatt A, et al, (1990) Evidence for terror management theory II: The effects of mortality salience on reactions to those who threaten or bolster the cultural worldview.. J Pers Soc Psychol 58 (2):308-318CrossRefGoogle Scholar
  41. Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R (2019) Survey of subjective "God encounter experiences": comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin LSD, ayahuasca, or DMT. PLoS One 14:e0214377PubMedPubMedCentralCrossRefGoogle Scholar
  42. Griffiths RR et al (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30:1181–1197PubMedPubMedCentralCrossRefGoogle Scholar
  43. Griffiths RR et al (2018) Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol 32:49–69PubMedCrossRefGoogle Scholar
  44. Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R (2011) Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology 218:649–665PubMedPubMedCentralCrossRefGoogle Scholar
  45. Griffiths RR, Richards WA, Johnson MW, McCann UD, Jesse R (2008) Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol 22:621–632PubMedPubMedCentralCrossRefGoogle Scholar
  46. Griffiths RR, Richards WA, McCann U, Jesse R (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187:268–283PubMedCrossRefGoogle Scholar
  47. Grof S (1972) Varieties of transpersonal experiences: Observations from LSD psychotherapy. J Transp Psychol 4:45Google Scholar
  48. Grof S, Goodman LE, Richards WA, Kurland A (1973) LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry 8:129–144PubMedCrossRefGoogle Scholar
  49. Halpern JH (2003) Hallucinogens: an update. Curr Psychiatry Rep 5:347–354PubMedCrossRefGoogle Scholar
  50. Harmer CJ, Goodwin GM, Cowen PJ (2009) Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195:102–108PubMedCrossRefGoogle Scholar
  51. Harmon-Jones E, Simon L, Greenberg J, Pyszczynski T, Solomon S, McGregor H (1997) Terror management theory and self-esteem: evidence that increased self-esteem reduced mortality salience effects. J Pers Soc Psychol 72:24PubMedCrossRefGoogle Scholar
  52. Hart J, Shaver PR, Goldenberg JL (2005) Attachment, self-esteem, worldviews, and terror management: evidence for a tripartite security system. J Pers Soc Psychol 88:999PubMedCrossRefGoogle Scholar
  53. Hartogsohn I (2018) The meaning-enhancing properties of psychedelics and their mediator role in psychedelic therapy, spirituality, and creativity. Front Neurosci 12:129PubMedPubMedCentralCrossRefGoogle Scholar
  54. Heflick NA, Goldenberg JL (2012) No atheists in foxholes: arguments for (but not against) afterlife belief buffers mortality salience effects for atheists. Br J Soc Psychol 51:385–392PubMedCrossRefGoogle Scholar
  55. Hendricks PS (2018) Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy. Int Rev Psychiatry 30(4):331–342 1-12PubMedCrossRefGoogle Scholar
  56. Hendricks PS, Johnson MW, Griffiths RR (2015) Psilocybin, psychological distress, and suicidality. J Psychopharmacol 29:1041–1043PubMedPubMedCentralCrossRefGoogle Scholar
  57. Holden C (1980) Arguments heard for psychedelics probe. Science 209:256–257PubMedCrossRefGoogle Scholar
  58. Hood RW Jr, Morris RJ (1983) Toward a theory of death transcendence. J Sci Study Relig:353–365CrossRefGoogle Scholar
  59. Huxley A (1954) The doors of perception. Harper & Row, New YorkGoogle Scholar
  60. Huxley LA (1968) This timeless moment: a personal view of Aldous Huxley. Farrar, Straus & GirousGoogle Scholar
  61. Iverach L, Menzies RG, Menzies RE (2014) Death anxiety and its role in psychopathology: reviewing the status of a transdiagnostic construct. Clin Psychol Rev 34:580–593PubMedCrossRefGoogle Scholar
  62. James W (2003) The varieties of religious experience: a study in human nature. Routledge,Google Scholar
  63. Jonas E, Fischer P (2006) Terror management and religion: evidence that intrinsic religiousness mitigates worldview defense following mortality salience. J Pers Soc Psychol 91:553PubMedCrossRefGoogle Scholar
  64. Kast EC, Collins VJ (1964) Study of lysergic acid diethylamide as an analgesic agent. Anesth Analg 43:285–291PubMedCrossRefGoogle Scholar
  65. Kesebir P (2014) A quiet ego quiets death anxiety: humility as an existential anxiety buffer. J Pers Soc Psychol 106:610PubMedCrossRefGoogle Scholar
  66. Kesebir P, Luszczynska A, Pyszczynski T, Benight C (2011) Posttraumatic stress disorder involves disrupted anxiety-buffer mechanisms. J Soc Clin Psychol 30:819–841CrossRefGoogle Scholar
  67. Kingman R (1928) Fears and phobias: part II Welfare. Magazine 19:303–308Google Scholar
  68. Kraehenmann R, Pokorny D, Vollenweider L, Preller KH, Pokorny T, Seifritz E, Vollenweider FX (2017) Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation. Psychopharmacology 234:2031–2046PubMedCrossRefGoogle Scholar
  69. Kunzendorf RG, McLaughlin S (1989) Depression: a failure to suppress the self-conscious ‘monitoring’of dismal cognitions Imagination. Cogn Personal 8:3–17CrossRefGoogle Scholar
  70. Le Marne KM, Harris LM (2016) Death anxiety, perfectionism and disordered eating. Behav Chang 33:193–211CrossRefGoogle Scholar
  71. Leary T, Litwin GH, Metzner R (1963) Reactions to psilocybin administered in a supportive environment. Journal of Nervous and Mental DiseaseGoogle Scholar
  72. Leary T, Metzner R, Albert R (1964) The psychedelic experience: a manual based on the Tibetan book of the dead New Hyde Park. University Books, New YorkGoogle Scholar
  73. Lifton RJ (1979) The broken connection: on death and the continuity of life. Simon & Schuster, New YorkGoogle Scholar
  74. Lilgendahl JP, Helson R, John OP (2013) Does ego development increase during midlife? The effects of openness and accommodative processing of difficult events. J Pers 81:403–416PubMedCrossRefGoogle Scholar
  75. Lyons T, Carhart-Harris RL (2018) Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. J Psychopharmacol 32(7):811–819 0269881117748902PubMedPubMedCentralCrossRefGoogle Scholar
  76. MacKenzie MJ, Baumeister RF (2014) Meaning in life: nature, needs, and myths. In: Meaning in Positive and Existential Psychology. Springer, pp 25-37Google Scholar
  77. Major RJ, Whelton WJ, Duff CT (2016) Secure your buffers or stare at the sun? Terror management theory and psychotherapy integration. J Psychother Integr 26:22CrossRefGoogle Scholar
  78. Martin LL, Campbell WK, Henry CD (2004) The roar of awakening: mortality acknowledgment as a call to authentic living. In: Greenberg J, Koole SL, Pyszczynski T (eds) Handbook of experimental existential psychology. Guilford Press, New York, pp 431–448Google Scholar
  79. Martz E (2004) Death anxiety as a predictor of posttraumatic stress levels among individuals with spinal cord injuries. Death Studies 28:1–17PubMedCrossRefGoogle Scholar
  80. Maslow AH (1943) A theory of human motivation. Psychol Rev 50:370CrossRefGoogle Scholar
  81. Masters R, Houston J (1966) The varieties of psychedelic experience: the classic guide to the effects of LSD on the human psyche. Simon and Schuster,Google Scholar
  82. Maxfield M, John S, Pyszczynski T (2014) A terror management perspective on the role of death-related anxiety in psychological dysfunction. Humanist Psychol 42:35–53CrossRefGoogle Scholar
  83. May R (1967) The meaning of anxiety, Revised edn. W.W Norton, New YorkGoogle Scholar
  84. Menzies RE (2018) Cognitive and behavioural procedures for the treatment of death anxiety. Curing the Dread of Death: Theory, Research and Practice:167Google Scholar
  85. Menzies RE, Dar-Nimrod I (2017) Death anxiety and its relationship with obsessive-compulsive disorder. J Abnorm Psychol 126:367PubMedCrossRefGoogle Scholar
  86. Menzies RE, Sharpe L, Dar-Nimrod I (2019) The relationship between death anxiety and severity of mental illnesses. Br J Clin Psychol 58(4):452–467PubMedCrossRefGoogle Scholar
  87. Menzies RE, Zuccala M, Sharpe L, Dar-Nimrod I (2018) The effects of psychosocial interventions on death anxiety: a meta-analysis and systematic review of randomised controlled trials. J Anxiety Disord 59:64–73PubMedCrossRefGoogle Scholar
  88. Menzies RG, Menzies RE, Iverach L (2015) The role of death fears in obsessive–compulsive disorder. Aust Clin Psychol 1:6–11Google Scholar
  89. Mikulincer M, Florian V, Hirschberger G (2003) The existential function of close relationships: introducing death into the science of love. Personal Soc Psychol Rev 7:20–40CrossRefGoogle Scholar
  90. Moody RA (1976) Life after life: the investigation of a phenomenon—survival of bodily death. Stackpole Books, HarrisburgGoogle Scholar
  91. Nour MM, Evans L, Carhart-Harris RL (2017) Psychedelics, personality and political perspectives. J Psychoactive Drugs 49:182–191PubMedCrossRefGoogle Scholar
  92. Nour MM, Evans L, Nutt D, Carhart-Harris RL (2016) Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum Neurosci 10:269PubMedPubMedCentralCrossRefGoogle Scholar
  93. Noyes R Jr (1980) Attitude change following near-death experiences. Psychiatry 43:234–242PubMedCrossRefGoogle Scholar
  94. Noyes R Jr (1983) The human experience of death or, what can we learn from near-death experiences? OMEGA-J Death Dying 13:251–259CrossRefGoogle Scholar
  95. Noyes R, Stuart S, Longley SL, Langbehn DR, Happel RL (2002) Hypochondriasis and fear of death. J Nerv Ment Dis 190:503–509PubMedCrossRefGoogle Scholar
  96. Osório FL et al (2015) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr 37:13–20CrossRefGoogle Scholar
  97. Pahnke W (1964) Drugs and mysticism: an analysis of the relationship between mystical consciousness and psychedelic drugs. Harvard University Ph. D. dissertationGoogle Scholar
  98. Pahnke WN (1969) The psychedelic mystical experience in the human encounter with death. Harv Theol Rev 62:1–21CrossRefGoogle Scholar
  99. Pahnke WN, Kurland AA, Unger S, Savage C, Grof S (1970) The experimental use of psychedelic (LSD) psychotherapy. Jama 212:1856–1863PubMedCrossRefGoogle Scholar
  100. Pahnke WN, Richards WA (1966) Implications of LSD and experimental mysticism. J Relig Health 5:175–208PubMedCrossRefGoogle Scholar
  101. Palhano-Fontes F et al (2018) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49(4):655–663 1-9PubMedCrossRefGoogle Scholar
  102. Passmore H-A, Howell AJ (2014) Eco-existential positive psychology: experiences in nature, existential anxieties, and well-being The. Humanist Psychol 42:370–388CrossRefGoogle Scholar
  103. Piff PK, Dietze P, Feinberg M, Stancato DM, Keltner D (2015) Awe, the small self, and prosocial behavior. J Pers Soc Psychol 108:883PubMedCrossRefGoogle Scholar
  104. Pollan M (2018) How to change your mind: the new science of psychedelics. Penguin Books Limited, LondonGoogle Scholar
  105. Preller KH et al (2017) The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Curr Biol 27:451–457PubMedCrossRefGoogle Scholar
  106. Pyszczynski T, Greenberg J, Solomon S, Hamilton J (1990) A terror management analysis of self-awareness and anxiety: The hierarchy of terror. Anxiety Research 2 (3):177-195CrossRefGoogle Scholar
  107. Pyszczynski T, Kesebir P (2011) Anxiety buffer disruption theory: a terror management account of posttraumatic stress disorder Anxiety. Stress Coping 24:3–26CrossRefGoogle Scholar
  108. Randall E (2001) Existential therapy of panic disorder: a single system study. Clin Soc Work J 29:259–267CrossRefGoogle Scholar
  109. Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T (2018) Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: a systematic review. Prog Neuro-Psychopharmacol Biol Psychiatry 81:1–10CrossRefGoogle Scholar
  110. Richards WA (1978) Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy. J Relig Health 17:117–126PubMedCrossRefGoogle Scholar
  111. Rieger D, Frischlich L, Högden F, Kauf R, Schramm K, Tappe E (2015) Appreciation in the face of death: Meaningful films buffer against death-related anxiety. J Commun 65:351–372CrossRefGoogle Scholar
  112. Rosenblatt A, Greenberg J, Solomon S, Pyszczynski T, et al, (1989) Evidence for terror management theory: I. The effects of mortality salience on reactions to those who violate or uphold cultural values.. J Pers Soc Psychol 57 (4):681-690PubMedCrossRefGoogle Scholar
  113. Roseman L, Nutt DJ, Carhart-Harris RL (2018) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol 8:974PubMedPubMedCentralCrossRefGoogle Scholar
  114. Routledge C, Juhl J (2010) When death thoughts lead to death fears: mortality salience increases death anxiety for individuals who lack meaning in life. Cognit Emot 24:848–854CrossRefGoogle Scholar
  115. Safren SA, Gershuny BS, Hendriksen E (2003) Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patient Care STDs 17:657–664PubMedCrossRefGoogle Scholar
  116. Sanches RF, de Lima Osório F, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE (2016) Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol 36:77–81PubMedCrossRefGoogle Scholar
  117. Sarnoff I, Corwin SM (1959) Castration anxiety and the fear of death. J Pers 27:374–385CrossRefGoogle Scholar
  118. Schmid Y, Liechti ME (2018) Long-lasting subjective effects of LSD in normal subjects. Psychopharmacology 235:535–545PubMedCrossRefGoogle Scholar
  119. Schmidt NB, Lerew DR, Trakowski JH (1997) Body vigilance in panic disorder: evaluating attention to bodily perturbations. J Consult Clin Psychol 65:214PubMedCrossRefGoogle Scholar
  120. Schneider KJ, Galvin J, Serlin I (2009) Rollo May on existential psychotherapy. J Human Psychol 49:419–434CrossRefGoogle Scholar
  121. Shiota MN, Keltner D, Mossman A (2007) The nature of awe: elicitors, appraisals, and effects on self-concept. Cognit Emot 21:944–963CrossRefGoogle Scholar
  122. Simon L, Arndt J, Greenberg J, Pyszczynski T, Solomon S (1998) Terror management and meaning: evidence that the opportunity to defend the worldview in response to mortality salience increases the meaningfulness of life in the mildly depressed. J Pers 66:359–382PubMedCrossRefGoogle Scholar
  123. Simon L, Greenberg J, Jones EH, Solomon S, Pyszczynsid T (1996) Mild depression, mortality salience and defense of the worldview evidence of intensified terror management in the mildly depressed. Personal Soc Psychol Bull 22:81–90CrossRefGoogle Scholar
  124. Starčević V (1989) Pathological fear of death, panic attacks, and hypochondriasis. Am J Psychoanal 49:347–361PubMedCrossRefGoogle Scholar
  125. Steele C, Kidd DC, Castano E (2015) On social death: ostracism and the accessibility of death thoughts. Death Studies 39:19–23PubMedCrossRefGoogle Scholar
  126. Stellar JE, Gordon A, Anderson CL, Piff PK, McNeil GD, Keltner D (2018) Awe and humility. J Pers Soc Psychol 114:258PubMedCrossRefGoogle Scholar
  127. Strachan E, Schimel J, Arndt J, Williams T, Solomon S, Pyszczynski T, Greenberg J (2007) Terror mismanagement: evidence that mortality salience exacerbates phobic and compulsive behaviors. Personal Soc Psychol Bull 33:1137–1151CrossRefGoogle Scholar
  128. Swanson LR (2018) Unifying theories of psychedelic drug effects. Front Pharmacol 9:172PubMedPubMedCentralCrossRefGoogle Scholar
  129. Tagliazucchi E et al (2016) Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr Biol 26:1043–1050PubMedCrossRefGoogle Scholar
  130. Timmermann C et al (2018) DMT models the near-death experience. Front Psychol 9:1424PubMedPubMedCentralCrossRefGoogle Scholar
  131. Tupper KW, Wood E, Yensen R, Johnson MW (2015) Psychedelic medicine: a re-emerging therapeutic paradigm. Can Med Assoc J 187:1054–1059CrossRefGoogle Scholar
  132. Vail KE, Rothschild ZK, Weise DR, Solomon S, Pyszczynski T, Greenberg J (2010) A terror management analysis of the psychological functions of religion. Personal Soc Psychol Rev 14:84–94CrossRefGoogle Scholar
  133. Yaakobi E (2018) Death thoughts mediate ostracism mood reduction: the moderating role of marital status. Motiv Emot 42(4):576–585 1-10CrossRefGoogle Scholar
  134. Yaden DB et al (2017a) Of roots and fruits: a comparison of psychedelic and nonpsychedelic mystical experiences. J Human Psychol 57:338–353CrossRefGoogle Scholar
  135. Yaden DB et al (2017b) The noetic quality: a multimethod exploratory study. Psychol Conscious Theory Res Pract 4:54CrossRefGoogle Scholar
  136. Yalom ID (1980) Existential psychotherapy, 1st edn. Basic Books, New YorkGoogle Scholar
  137. Yalom ID (2008) Staring at the sun: overcoming the terror of death. Human Psychol 36:283–297Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.School of PsychologyUniversity of WollongongWollongongAustralia
  2. 2.School of PsychologyUniversity of SydneyCamperdownAustralia

Personalised recommendations